The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Home > Documents > Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with warrants of Sopharma AD as of 3 September 2024
Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with warrants of Sopharma AD as of 3 September 2024